Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic

Authors:

Abstract
Mental health disorders are identified as one of the most significant challenges in pediatric health care.1,2 Their prevalence has been increasing over the years, and currently almost 15% of children and adolescents are diagnosed with a mental disorder by the age of 18 years.3 In this context, the COVID-19 pandemic has been a major aggravating factor with an unprecedented, large-scale negative impact on mental health. Several studies have described a substantial deterioration of mental well-being in children and young people after the onset of the pandemic, with increases in health care needs.4-6

This publication has 46 references indexed in Scilit: